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Summary Statement: Qualitative analysis of SD-OCT scans of retinal 
neovascularization in proliferative diabetic retinopathy identified 5 distinct signs of 
disease activity: presence of hyperreflective dots in the vitreous, epiretinal 
membrane, inner retinal tissue contracture, vitreous invasion and protrusion towards 
vitreous. 
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Abstract: 
	
Purpose: To describe spectral domain optical coherence tomography (SD-
OCT) features of retinal neovascularization in proliferative diabetic retinopathy (PDR) 
and thus to identify novel signs of new vessel activity. 
Methods: Retrospective, cross-sectional study. Data were collected over a 
nine-month period. SD-OCT scans were performed over areas of new vessel 
complexes (NVC) in both the disc (NVD) and elsewhere (NVE), and were 
qualitatively graded by two masked observers. NVC activity was determined using 
clinical and angiographic criteria and correlated with SD-OCT features. 
Results: 43 eyes of 30 patients with PDR were included. 61 NVC lesions 
(NVD-37.7%, NVE-62.3%) were captured by SD-OCT and analyzed. 63.9% were 
classified as active and 36.1% as quiescent. Five distinctive features were identified 
as significantly different between active and quiescent NVC: presence of vitreous 
hyperreflective dots in active NVC (p=0.002) and presence of epiretinal membrane 
(p=0.04), inner retinal tissue contracture (p=0.03), vitreous invasion (p=0.02) and 
protrusion towards vitreous (p=0.002) in quiescent NVC.  
Conclusions:  In this exploratory study, the presence of vitreous 
hyperreflective dots, epiretinal membrane, inner retinal tissue contracture, vitreous 
invasion and vitreous protrusion were identified as distinct signs of disease activity. 
Such parameters may be useful as a non-invasive imaging modality in eyes 
undergoing treatment for PDR. 
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Introduction: 
	
Diabetic retinopathy, a microvascular complication of diabetes mellitus (DM),1,2 can 
be clinically classified as non-proliferative or proliferative diabetic retinopathy 
(PDR).3, 4 PDR, which occurs in up to 50% in type 1, and 15% in type 2 diabetes, 
remains a major cause of visual disability.5 The classification of the new vessels 
depends on their location; neovascularization of the disc (NVD) if they are on the 
disc or within one disc diameter of the optic disc, or neovascularization elsewhere 
(NVE) if they are located more than one disc diameter from the disc margin.3  
Optical coherence tomography (OCT), is a non-invasive imaging method6 that 
has changed how diabetic retinopathy is investigated, and has been widely adopted 
for the assessment of diabetic macular edema, both in clinical practice and clinical 
trials. It has also increased our understanding of how the disease affects the different 
layers of the retina and choroid, in particular, for the identification of retinal 
thickening, intra-retinal edema and changes of the vitreoretinal interface.7-10		
Recently, it has been shown that it is possible to use spectral-domain OCT (SD-
OCT) to evaluate the morphologic features of PDR. This could be useful in 
evaluating new vessel complexes (NVC) in their earliest stages, but also to identify 
associated vitreoretinal changes.11 While NVD were first described as a 
hyperreflective lesion sitting over the optic disc or protruding from it, NVE were seen 
as flat vessels arising from the inner retina which then grew as hyperreflective 
loops.11,12 Adhesion and break through the posterior hyaloid, traction and vitreous 
invasion were also observed.11,12 Nevertheless, although SD-OCT is helpful in 
showing early and established NVC, while providing anatomic relationships and 
being in some cases more accurate than clinical examination or fluorescein 
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angiography, there is still limited evidence regarding the usefulness of this technique 
in determining disease activity.11-14 Indeed, there have been no studies which 
address its potential to assess new vessel activity. In the landmark clinical trials of 
the Diabetic Retinopathy Study (DRS) and Early Treatment Diabetic Retinopathy 
Study (ETDRS), fluorescein angiography (FA) was used as an adjunct for the 
classification of disease severity, guiding laser therapy and evaluating the response 
to treatment.15-17 In large multicenter clinical trials, FA is usually not required, and 
performed at the investigator’s discretion.18 In clinical practice however, it is often 
used to ascertain new vessel activity in the context of evaluating the response to 
treatment. As fluorescein angiography is an invasive procedure, it is not performed 
with the same frequency as SD-OCT. Identifying SD-OCT derived features of new 
vessel activity will enable the clinician to more closely monitor patients, and 
consequently tailor management decisions according to the individual’s response to 
treatment – i.e., during a course of pan-retinal laser photocoagulation, or intravitreal 
pharmacotherapy.  
In this study, we investigate the use of SD-OCT to describe features of retinal 
neovascularization in PDR, in an effort to identify novel signs of new vessel activity.  
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Material and Methods: 
	
Inclusion Criteria and Data Collection: 
Forty-three eyes of 30 non-consecutive patients with PDR, either with NVD or NVE, 
active or quiescent, as assessed by ophthalmoscopy according to the Early 
Treatment Diabetic Retinopathy Study (ETDRS) criteria were included.3 Clinical data 
collected included age, gender, disease type (type 1 and type 2 DM), best-corrected 
visual acuity (Snellen acuity charts), history of previous laser treatments and central 
macular thickness (CMT) in both eyes (Table 1). Patient demographic data, visual 
acuity and retinopathy grading were obtained from standardized electronic reports in 
the United Kingdom National Screening Committee (UK NSC) - Diabetic Eye 
Screening Programme, as described elsewhere.19 The baseline clinical 
characteristics of eyes included in the study are described in Table 2. Regarding 
NVC location, NVD were defined as complexes located in the disc or within 1DD 
from its margin, and NVE were defined as NVC located outside this area. NVC 
activity was ascertained using clinical examination, color fundus photographs and 
fluorescein angiography (FA). 
Active NVC were considered to have a perfused blood column on fundoscopy and 
leakage seen in FA, while inactive NVC showed no red blood column present on 
fundoscopy and no obvious leakage in FA.3		Exclusion criteria included other causes 
of proliferative retinopathy such as retinal arterial and venous occlusion, ocular 
ischemic syndrome, radiation retinopathy or sickle cell retinopathy.	
This data was collected over a nine-month period (May 2012 to January 2013) 
from medical retina clinics with a focus on diabetic eye disease at Moorfields Eye 
Hospital, London, United Kingdom and at the Department of Ophthalmology, 
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Hospital de Santa Maria, Lisbon, Portugal. Approval for data collection and analysis 
was obtained from the Moorfields Eye Hospital and Hospital de Santa Maria local 
ethics committee. This study was carried out according to the tenets set forth in the 
Declaration of Helsinki. 
 
OCT Image Acquisition Protocol: 
OCT images sets were obtained by experienced operators (B.S. and S.V.P.), using a 
standard, commercially available SD-OCT device (SPECTRALIS®, Heidelberg 
Engineering, Heidelberg, Germany). In each case, both macular and extramacular 
raster scan acquisition protocol were performed, centered on the fovea and the NVC 
respectively. SD-OCT images at the NVC were selected either with the vertical or 
horizontal scanning plane bisecting the NVC and the image sets size was adjusted 
accordingly in order to include the whole extent of the NVC, using equally spaced 
OCT B-scan sections, each composed of 50-100 averaged B-scans.  
 
Qualitative analysis of OCT images: 
All SD-OCT image sets were reviewed independently by two retina specialists 
(S.V.P. and D.A.S.) who were masked to the clinical information at the time of the 
assessment. Each image set was assessed for the presence of tomographic 
features which included vitreoretinal, retinal and NVC morphologic parameters 
(Table 3). Vitreoretinal parameters included 1) posterior vitreous detachment (PVD), 
defined as a detached posterior hyaloid seen as a thin hyperreflective layer above 
the internal limiting membrane (ILM); 2) thickening of the posterior hyaloid; 3) 
epiretinal membrane (ERM) in the area of the NVC, defined as a hyperreflective 
band anterior to the inner retinal surface, 4) presence of vitreoretinal traction with 
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retinal distortion; and 5) presence of hyperreflective dots in the vitreous cavity. 3D 
OCT maps were also evaluated in order to identify further vitreoretinal traction, such 
as tractional retinal detachment. 
Retinal features included 1) evidence of retinal tissue contracture, seen as 
mechanical tractional changes at the NVC and surrounding retina causing distortion; 
2) intra-retinal cysts identified as round or oval hyporreflective areas within the retina; 
and 3) retinal hyperreflective dots, seen as hyperreflective dots within the retinal 
layers. NVC parameters were graded according to 1) reflectivity of the NVC, being 
“medium” reflectivity if it was between the high reflectivity of the retinal pigment 
epithelium (RPE) and the hyporreflectivity from outer nuclear layer, and “high” if 
equal or greater in reflectivity than the RPE; 2) shadowing of the outer retina; 3) 
vitreous invasion, regarded as invasion through the posterior hyaloid / vitreous 
cavity; and 4) relative position of the NVC with regards to the retina (flat/protruding). 
In case of disagreement between graders, open adjudication was performed to 
obtain the final grading. A subset of images was then regraded at a later point to 
assess reproducibility.  
 
Statistical Analysis: 
Clinical and imaging data were analyzed with frequency and descriptive statistics. 
CMT was measured using the EDTRS foveal central subfield on macular SD-OCT. 
Snellen visual acuities were converted to logMAR visual acuities for the purposes of 
statistical analysis. 
The Fisher’s exact test was used for statistical analysis of categorical variables in 
eyes with NVD, and the Chi-Squared test in eyes with NVE. The two-tailed t-test and 
the Mann-Whitney U test were used for continuous variables. Concordance between 
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graders for the qualitative SD-OCT features assessed was determined with κ index. 
For the strength of agreement range, we considered 0.21-0.40 to be fair agreement, 
0.41-0.60 moderate agreement, 0.61-0.80 substantial agreement and 0.81-1.00 
almost perfect agreement, as per previous suggested guidelines.20 Results with a P 
value < 0.05 were considered statistically significant. Statistical analyses were 
performed using SPSS software version 16 (SPSS, Inc, Chicago, IL). 
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Results: 
 
Baseline characteristics of patients and eyes analyzed: 
The baseline demographics and clinical characteristics of the 30 patients included in 
the study are summarized in Table 1. The mean age was 55.6 years (Standard 
Deviation [SD]: 11.8) and 16 (53.3%) were male. Eight (26.7%) had type 1 and 22 
(73.3%) had type 2 diabetes. Six patients (20%) had previous laser 
photocoagulation. Retinopathy grading was obtained from the standardized elec- 
tronic reports as per the U.K. NSC with 10 (33.3%) patients being RP MP (diabetic 
retinopathy and maculopathy treated with laser) in both eyes, seven (23.3%) being 
RP M0 (diabetic retinopathy treated with laser and no maculopathy) in both eyes, 
two (6.7%) patients being bilaterally R3 M0 (PDR and no maculopathy), two (6.7%) 
patients graded bilaterally as R3 M1 (PDR with maculopathy), two (6.7%) pa- tients 
being bilaterally RP M1 (diabetic retinopathy treated with laser and maculopathy) 
and seven (23.3%) patients having different grading between eyes. Disease activity 
was documented by clinical examination alone in 4 patients (13.3%), by additional 
color photographs in 7 patients (23.3%) and by fluorescein angiography in 19 
patients (63.6%).  
A total of 43 eyes were analyzed, 8 eyes had both NVD and NVE and 5 eyes 
had more than one focus of NVE. Four eyes had NVD and 8 eyes had NVE 
bilaterally. Mean logMAR visual acuity was 0.24 (SD: 0.19), 35 (81.4%) eyes had 
had previous laser panretinal photocoagulation at the time of the SD-OCT scan and 
the mean CMT was 311.3 µm (SD: 91.0). The mean age, sex, visual acuity and CMT 
did not differ significantly between eyes with active or quiescent new vessels (Table 
2). A significant difference was observed regarding disease activity and the type of 
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diabetes and presence of previous laser treatment: most of the active eyes were of 
type 2 diabetics (77.8% vs 56.2%) and only 74% vs 93.8% had previous laser 
photocoagulation (p=0.01 and p=0.001, respectively). 
 
Assessment of SD-OCT Features in New Vessel Complexes: 
Sixty-one NVC were scanned, among which 23 (37.7%) were NVD and 38 (62.3%) 
NVE. All NVE were located posterior to equator with 13 (34.2%) being positioned 
inside the temporal arcades and 25 (65.8%) outside the arcades. The NVE were 
located in the superotemporal quadrant in 47.4% of cases, followed by the 
inferotemporal quadrant in 23.7%, the inferonasal quadrant in 21,1% and the 
superonasal quadrant in 7.9%. Active NVC represented 63.9% of the studied sample 
(39/61), whereas quiescent NVC included 36.1% (22/61). Regarding subgroups by 
NVC location and disease activity, 65.2% (15/23) of NVD and 63.2% (24/38) of NVE 
were active in the moment of the scan. All SD-OCT derived morphologic features of 
the NVD and NVE assessed are summarized in Table 3.  
SD-OCT characteristics of NVC: Mostly of the scanned NVC revealed 
thickening of the posterior hyaloid (79.5% for active NVC, 45.5% for inactive NVC 
respectively) without signs of vitreoretinal traction (79.5%, 59.1%), no intraretinal 
cysts (76.9%, 63.6%) but presence of hyperreflective dots in the retina (66.7%, 
54.5%), and no hyperreflective changes with regards to RPE layer (51.3%, 59.1%) 
but shadowing of the outer retinal layers (92.3%, 86.4%), without significant 
differences between active and inactive NVC. 
Features of active versus inactive neovascularization at the disc (NVD): 
Absence of posterior vitreous detachment was significantly more frequent in active 
NVD (93.3% vs 50%, 14/15 vs 4/8, p=0.03), however vitreous invasion was seen in 
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all quiescent cases (100%, 8/8) compared to active NVD complexes (40.0%, 6/15, 
p=0.02) (Figure 1). There were no significant differences in any of the other 
parameters evaluated.  
Features of active versus inactive neovascularization elsewhere (NVE): The 
presence of hyperreflective dots in the vitreous overlying NVE was significantly more 
frequent in active NVE (70.8%, 17/24) than in quiescent NVE (21.4%, 3/14, p=0.009) 
(Figure 2a and Figure 3e-f). Active NVE sit flat on the retinal surface (66.7%, 16/24) 
(Figure 2a and Figure 3) significantly more than quiescent cases, which tended to 
protrude towards vitreous (85.7%, 12/14, p=0.005, Figure 2b-d). Both NVC 
presented with diverse shapes which included loops, C-shapes, funnel shape and a 
horizontal string. No other parameters were significantly associated with disease 
activity. 
Shared features of active versus inactive NVD and NVE: A combined analysis 
of NVD and NVE complexes showed a significantly higher presence of 
hyperreflective dots in vitreous in active NVC (66.7%, 22/39) than in quiescent NVC 
(22.7%, 5/22)(p=0.002). The presence of ERM was more frequently observed in 
quiescent NVC (100%, 22/22) than in active NVC (76.9%, 30/39, p=0.002) (Figure 1 
and Figure 2b-d), as was tissue contracture (77.3%, 17/22 vs 46.2%, 18/39, p=0.04). 
Vitreous invasion was more frequently observed in quiescent NVC (90.9%, 20/22) 
than active NVC (51.3%, 20/29, p=0.02), and indeed quiescent cases tended to 
protrude towards vitreous (86.4%, 19/22) significantly more than active NVC (41%, 
16/39, p=0.002). None of the other parameters showed significant differences 
between groups (Table 3). 
Sensitivity, specificity, and predictive values of OCT in the determination of 
PDR activity: They were, respectively 66.70%, 77.30%, 83.90% and 56.67% for the 
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presence of vitreous hyperreflective dots; 76.92%, 0%, 57.69% and 0% for the 
presence of ERM; 46.15%, 22.73%, 51.42% and 19.23% for inner retinal tissue 
contracture; 51.28%, 9.00%, 50% and 9.52% for vitreous invasion and for 58.97%, 
86.36%, 88.46% and 54.28% for vitreous protrusion.  
 Intergrader agreement: The intergrader agreement for the SD-OCT features 
accessed was substantial with a weighted kappa of 0.64 (Standard error: 0.13, 95% 
CI: 0.41 to 0.94). 
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Discussion: 
 
In this study, we used SD-OCT, a non-contact, non-invasive imaging technique, to 
describe the morphology of retinal neovascularization in PDR, with the aim of 
identifying specific SD-OCT signs of new vessel activity. For the purposes of this 
study, we designed a customized scanning protocol to better capture the NVC within 
the SD-OCT scan. As previously documented by Cho et al, we were successful in 
imaging all NVC.11  
 Differences in SD-OCT features were observed between active and inactive 
NVC. Muqit et al have also recently described OCT features in PDR12, 13, albeit with 
different descriptive terms.  The present study has identified a significant higher 
presence of vitreous hyperreflective dots in active NVC compared to quiescent NVC 
with good sensibility. We hypothesize that this feature may be related to the 
increased vascular permeability of the NVC lesions during the active phase, leading 
to extravasation of sero-sanguineous components into the adjacent vitreous. We 
suggest that this material may lately coalesce in clusters, with hyperreflective optical 
properties. It should be mentioned that frank vitreous hemorrhage (VH) was not 
present in the image sets obtained in this study, although the presence of subclinical 
VH could not be completely excluded. Conversely, quiescent NVC were more 
commonly associated with qualitative features related to fibrotic changes. These 
included the presence of ERM adjacent to NVC, as well as inner retinal tissue 
contracture and vitreous invasion. In addition, most quiescent NVC demonstrated 
lesion protrusion towards the vitreous. These statistically significant findings may 
relate with the retraction, scaring and fibrosis that arises with the involution of the 
vessels after laser treatment. As in previous studies, there was a lower prevalence of 
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active NVC in eyes with previous panretinal laser photocoagulation.21  
 Most of the NVC included in our study had a thickened attached posterior 
hyaloid and were not associated with a PVD. These results are consistent with 
previous published studies. In a shorter series (n=16), Cho et al., reported that NVC 
lesions were found to arise at a vitreous attachment site, where the thickened 
posterior hyaloid would have served as scaffold for the growth of NVC.11 
Interestingly, Ono et al., concluded in a much larger prospective study (n=403) that a 
complete PVD seemed to be protective for the development of PDR.22 Our results 
are consistent with this data, given that only a small number of NVC was associated 
with a complete PVD (6.5%, 4/61). In keeping with this, the majority of the NVC, and 
especially the quiescent cases, demonstrated NVC lesions protruding towards the 
vitreous from the surface of the retina, as described by Cho et al as a second 
category of NVC.12 Other features analyzed in this study included the presence of 
retinal hyperreflective dots and intraretinal cysts. Whereas these retinal 
hyperreflective dots have been reported to be activated microglial cells in age-related 
macular degeneration, in other diseases they have been described as vessel hyper-
permeability products in the form of proteins or lipid deposits.23,24 Given the vascular 
abnormalities seen in PDR, the latter appears to be a sensible explanation for the 
findings observed. Regarding the presence of intraretinal cysts, only a quarter of the 
lesions presented this finding without any differences among active and inactive 
NVC.  
The current study has a number of strengths. To our knowledge this is the first 
study that analyzes qualitative data from SD-OCT scans in a relatively large series of 
PDR eyes in an effort to identify signs of NVC activity. All OCT images were 
assessed by masked experienced graders with substantial intergrader agreement. 
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Moreover, our scanning protocol can be easily performed using standard SD-OCT 
devices, allowing replication of the current study in different populations. Limitations 
include selection bias as it was a cross-sectional study with a limited cohort recruited 
in two tertiary referral specialized medical retina clinics. As a result, the cases 
evaluated may represent more advanced PDR than those seen in a standard 
community setting. Also, as this was an exploratory study, our sample was 
insufficient to include multiple comparisons, such as cross match between vitreous 
and retinal features, and for appropriate test validation. It should be regarded as a 
hypothesis generator that needs to be confirmed in larger studies. Another important 
consideration is the fact that the majority of eyes (81.4%) were previously submitted 
to panretinal photocoagulation so it is possible that the higher incidence or ERM in 
the quiescent NVC group was due to the laser treatment and not to the 
neovascularization inactivity. Additionally, as majority of our patients did not have a 
PVD, we were unable to correlate the growth of NV into the vitreous with incomplete 
PVD. An additional limitation is the inability of SD-OCT to capture the totality of the 
NVC area, as seen on slit-lamp biomicroscopy. Future developments in OCT 
technology may overcome this limitation by allowing image capture over wider areas 
of the retina, as well as visualization of more peripheral retinal pathologies.  
 In conclusion, this study reports that commercially available SD-OCT devices 
can be used to assess features of NVC in patients with diabetic retinopathy. This is a 
relatively new field and the present study differs from previous reports as it was 
designed to establish whether SD-OCT can match the clinical determination of 
disease state. Five distinctive signs were identified as significantly different between 
active and quiescent NVC: presence of vitreous hyperreflective dots in active NVC 
and presence of epiretinal membrane, inner retinal tissue contracture, vitreous 
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invasion and protrusion towards vitreous in quiescent NVC. In that respect, our 
results suggest that OCT may be useful for distinguishing between active and 
quiescent NVC and may be useful with regard to clinical decision-making and 
monitoring response to treatment.  
Interestingly, the use of the confocal scanning laser ophthalmoscope eye-
tracking system employed by the SD-OCT device could allow repeated OCT scan 
captures in the exact location of lesions, providing an exceptional tool to monitor 
NVC evolution or response to treatment during follow up. With this aim further 
longitudinal studies including larger cohorts of patients are required to confirm these 
preliminary findings, as well as to evaluate their relationship with other imaging 
techniques such as fluorescein angiography and elucidate the real potential of this 
non-invasive imaging technique in assessing new vessel activity in PDR. 
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Figure legends: 
 
Figure 1. (a) Colour fundus photograph of a patient with inactive NVD. (b)  
Late phase fundus fluorescein angiogram showing no leakage from the NVD. (c)  
3D spectral-domain optical coherence tomography (SD-OCT) reconstruction of the 
NV complex showing its protrusion from the disc. (d) Green horizontal lines 
represent SD-OCT B-scans through the NVD. The NV invades the vitreous and is 
associated with tissue contracture, an epiretinal membrane and retinal and vitreous 
hyperreflective dots. 
 
Figure 2. (i) Examples of 3D spectral-domain optical coherence tomography (SD-
OCT) reconstructions of the NVE complexes, (a) active and (b-d) inactive. (ii) 
Examples of SD-OCT B-scans through the NV. Horizontal arrow lines represent the 
plane of the scan. (a) Vitreous hyperreflective dots. Flat active NVE with associated 
vitreous hyperreflective dots. (b) Vitreous invasion. Inactive NVE with vitreous 
invasion, intra-retinal cysts and features of tissue contracture. (c) Epiretinal 
membrane adjacent to NVC. Protruding inactive complex with an associated 
epiretinal membrane (ERM) and retinal hyperreflective dots (arrowheads). (d) C-
shaped NV complex with ERM and features of tissue contracture.  
 
Figure 3. (a) Colour fundus photograph of a patient with active NVE. (b)  
Magnification of the annotated area in 2a showing the NVE in detail. (c) Early phase 
fundus fluorescein angiogram demonstrating temporal capillary non-perfusion and 
leakage from the NV complex, which (d) increased in size and intensity through the 
study, corresponding to active disease. (e-f) Green horizontal lines represent 
spectral-domain optical coherence tomography B-scans through the NVE. (e) 
Depicted area is enlarged and shows a flat NVE complex with vitreous invasion (red) 
and associated vitreous hyperreflective dots (green). (f) Magnification of the 
delineated area shows in more detail the dilated tips of the NVE (red) and the  
hyperreflective dots (green). 
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Table 1. Baseline Demographics and Clinical Characteristics of Patients with Neovascularization of the Disc and Elsewhere. 
 No PRP, n= 6 PRP, n= 24  
Age, y, mean (SD) 49 57.2  
Gender, n, female/male 1/5 13/11  
Type of DM, n, 1/2 1/5 7/17  
VA, logMAR, mean (SD) OD/OS 0.27(0.25)/ 0.26(0.27) 0.27(0.24)/0.29(0.37)  
CMT, µm, mean (SD) OD/OS 323.0 (36.40) / 366.5 (77.48)	 292.79 (110.06) / 316.64 (86.36)	  
Eyes analyzed, n, 1/2 4/2 13/11  
Type of SD-OCT scan obtained   
 
          NVD 3 8 
          NVE 1 10 
          Both 2 6 
Number of SD-OCT scans obtained   
          NVD 6 17 
          NVE 3 35 
Abbreviations: y = years; PRP = panretinal photocoagulation; DM = Diabetes Mellitus; NVD = Neovascularization of the Disc; NVE =  
Neovascularization Elsewhere; OD = Right eye; OS = Left eye; CMT = Central Macular Thickness; SD-OCT = Spectral-Domain Optical Coherence 
Tomography 
 
 
Table 2. Baseline Clinical Characteristics of the Eyes with Neovascularization of the Disc and Elsewhere. 
 
The Chi-Squared test was used for statistical analysis of categorical and the Mann-Whitney U test for continuous variables. p values significant at 5% level are indicated with (*), 
and (†) at 1% level. Abbreviations: DM = Diabetes Mellitus; NVD = Neovascularization of the Disc; NVE = Neovascularization Elsewhere; SD= Standard Deviation; OD = Right 
eye; OS = Left eye; CMT = Central Macular Thickness; SD-OCT= Spectral Domain Optical Coherence Tomography; VA = Visual Acuity 
 
 
 
 
Age 
(Years) 
(Mean 
[SD]) 
p-value 
Male 
Sex, n 
(%) 
p-value 
Right 
Eye, n 
(%) 
p-value 
Type 1 or 
2 DM n 
(%) 
p-value 
logMAR 
VA 
(Mean 
[SD]) 
p-value 
Laser 
photocoagulation 
at the time of SD-
OCT scan,  n (%) 
p-value 
CMT (um) 
(Mean 
[SD]) 
p-value 
Eyes               
All 
(n=43) 
54.9 
[12.3]  
24 
(55.8)  
20 
(87.0)  
13 (30.2) 
Type 1; 
30 (69.8) 
Type 2 
 0.24 [0.19]  35 (81.4)  
311.3 
[91.0]  
Active 
NVD/E 
(n=27) 
55.7 
[12.6] 
0.51 
18 
(66.6) 
0.45 
13 
(48.1) 
0.65 
6 (22,2) 
Type 1; 
21 (77.8) 
Type 2 
0.01* 
0.24 
[0.22] 
0.61 
20 (74.0) 
0.001† 
326.5 
[104.8] 
0.17 
Inactive 
NVD/E 
(n=16) 
53.4 
[12.0] 
6 
(37.5) 7 (43.8) 
7 (43.8) 
Type 1; 9 
(56.2) 
Type 2 
0.24 
[0.13] 15 (93.8) 
285,7 
[55.0] 
1	
	
Table 3. Assessment of SD-Optical Coherence Tomographic Features of Neovascularization of the Disc and 
Elsewhere 
 
SD-OCT Features 
NVD NVE Combined NVD/E 
Active Quiescent p-value Active Quiescent p-value Active Quiescent p-value 
 (n [%]) (n [%]) 
 
(n [%]) (n [%]) 
 
(n [%]) (n [%]) 
 
All SD-OCT scans 15 [65,2] 8 [34,8] 24 [63,2] 14 [36,8] 39 [63,9] 22 [36,1] 
Vitreoretinal morphologic parameters 
Posterior vitreous 
detachment  
Yes 0 (0) 0 (0) 
0,03* 
1 (4,20) 3 (21,4) 
0,12 
1 (2,6) 3 (13,6) 
0,10 
No 14 (93,3) 4 (50,0) 23 (95,8) 7 (50,0) 37 (94,9) 11 (50,0) 
Thickening of the posterior 
hyaloid  
Yes 12 (80,0) 4 (50,0) 
0,71 
19 (79,2) 6 (42,9) 
0,81 
31 (79,5) 10 (45,5) 
0,68 
No 2 (13,3) 2 (25,0) 5 (20,8) 2 (14,3) 7 (17,9) 4 (18,1) 
ERM at NVC           
Yes 11 (73,3) 8 (100) 
0,30 
19 (79,2) 14 (100) 
0,18 
30 (76,9) 22 (100) 
0,04* 
No 4 (26,7) 0 (0) 5 (20,8) 0 (0) 9 (23,1) 0 (0) 
Vitreoretinal traction  
Yes 5 (33,3) 5 (62,5) 
0,37 
3 (12,5) 4 (28,6) 
0,13 
8 (20,5) 9 (40,9) 
0,16 
No 10 (66,7) 3 (37,5) 21 (87,5) 10 (71,4) 31 (79,5) 13 (59,1) 
Hyperreflective dots in the 
vitreous  
Yes 9 (60,0) 2 (25,0) 
0,25 
17 (70,8) 3 (21,4) 
0,009† 26 (66,7) 5 (22,7) 0,002† No 6 (40,0) 6 (75,0) 7 (29,2) 11 (78,6) 13 (33,3) 17 (77,3) 
Retinal morphologic parameters 
Retinal tissue contracture  
Yes 10 (66,7) 8 (100) 
0,19 
8 (33,3) 9 (64,3) 
0,13 
18 (46,2) 17 (77,3) 
0,03* 
No 5 (33,3) 0 (0) 16 (66,7) 5 (35,7) 21 (53,8) 5 (22,7) 
Intraretinal cysts  
Yes 2 (13,3) 0 (0) 
0,76 
7 (29,2) 6 (42,9) 
0,50 
9 (23,1) 6 (27,3) 
0,88 
No 13 (86,7) 8 (100) 17 (70,8) 6 (42,9) 30 (76,9) 14 (63,6) 
Retinal hyperreflective dots  
Yes 8 (53,3) 3 (37,5) 
0,78 
18 (75,0) 9 (64,3) 
0,99 
26 (66,7) 12 (54,5) 
0,65 
No 7 (46,7) 5 (62,5) 6 (25,0) 4 (28,6) 13 (33,3) 9 (40,9) 
NVC morphologic parameters 
Reflectivity of NVC          
High 7 (46,7) 3 (37,5) 0,98 12 (50,0) 6 (42,9) 0,93 19 (48,7) 9 (40,9) 0,59 
Medium 8 (53,3) 5 (62,5)  12 (50,0) 8 (57,1)  20 (51,3) 13 (59,1)  
Shadowing outer retina          
Yes 12 (80,0) 8 (100) 0,48 24 (100) 11 (78,6) 0,08 36 (92,3) 19 (86,4) 0,76 
No 3 (20,0) 0 (0)  0 (0) 3 (21,4)  3 (7,7) 3 (13,6)  
Vitreous invasion          
Yes 6 (40,0) 8 (100) 0,02* 14 (58,3) 12 (85,7) 0,16 20 (51,3) 20 (90,9) 0,02* 
No 9 (60,0) 0 (0)  10 (41,7) 2 (14,3)  19 (48,7) 2 (9,1)  
Relative position of NVC          
Flat 7 (46,7) 1 (12,5) 0,24 16 (66,7) 2 (14,3) 0,005† 23 (59,0) 3 (13,6) 0,002† 
Protruding 8 (53,3) 7 (87,5)  8 (33,3) 12 (85,7)  16 (41,0) 19 (86,4)  
The Fisher’s exact test was used for statistical analysis of categorical variables in eyes with NVD, and the Chi-Squared 
test in eyes with NVE. The two-tailed t-test was used for continuous variables in all eyes. p values significant at 5% 
level are indicated with (*), and (†) at 1% level. Abbreviations: NVC= New Vessel Complex; NVD = Neovascularization 
of the Disc; NVE = Neovascularization Elsewhere; SD-OCT = Spectral-Domain Optical Coherence Tomography; ERM 
= epiretinal membrane  
